Literature DB >> 1657855

The in-vitro activity of temafloxacin compared with other antimicrobial agents.

A King1, L Bethune, I Phillips.   

Abstract

Temafloxacin, like other 4-quinolones, was highly active against most isolates of Enterobacteriaceae. It was slightly less active than ciprofloxacin but approximately as active as ofloxacin and enoxacin. It was the most active of the quinolones against Acinetobacter spp. and Xanthomonas maltophilia but was slightly less active than ciprofloxacin against Pseudomonas spp. Temafloxacin was highly active against Haemophilus influenzae, Moraxella catarrhalis and Neisseria gonorrhoeae and was the most active of the quinolones against Gardnerella vaginalis and Campylobacter coli/jejuni. It was more active than ciprofloxacin against most staphylococci and equally active against streptococci and enterococci. Temafloxacin was the most active quinolone against anaerobic bacteria and, with the exception of a few isolates of Bacteroides spp. and some clostridia, all anaerobes were within the sensitive range (MIC less than or equal to 2 mg/l).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657855     DOI: 10.1093/jac/27.6.769

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

2.  Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.

Authors:  P C Appelbaum; S K Spangler; R Shiman; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.

Authors:  J J Clement; S K Tanaka; J Alder; C Vojtko; J Beyer; D Hensey; N Ramer; D McDaniel; D T Chu
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

4.  In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.

Authors:  R K Flamm; C Vojtko; D T Chu; Q Li; J Beyer; D Hensey; N Ramer; J J Clement; S K Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.